New pathways to research commercialisation - EQUS & FLEET Seminar
New pathways to research commercialisation
Hear from Australian tech investors reinventing how researchers become entrepreneurs.
Join us to hear from Alezeia Brown (Main Sequence Ventures) and Clare Birch (Blackbird Ventures) about two exciting new ways for researchers in deep tech to become entrepreneurs and commercialise their research.
Main Sequence Ventures have pioneered Venture Science – a repeatable way to grow the next generation of impactful companies with science at the core. Venture Science combines the mindset and tactics of venturing with the problem-solving depth of science to make giant leaps of progress.
Foundry is Blackbird’s flagship deep/bio-tech founder product. Blackbird says that research-led companies will cornerstone the solutions to humanity’s greatest problems. Foundry is their invitation to PhD students, EMCRs, and established researchers to imagine a better future and learn how to build it.
We will leave plenty of time for questions and discussion.
When: Tuesday Sep 5, 2023 ⋅ 12pm – 1pm (Eastern Australia Time - Sydney)
Location: Zoom link will be provided when you register at https://www.fleet.org.au/blog/events/new-pathways-to-research-commercialisation
Major funding support
The Australian Research Council Centre of Excellence for Engineered Quantum Systems (EQUS) acknowledges the Traditional Owners of Country throughout Australia and their continuing connection to lands, waters and communities. We pay our respects to Aboriginal and Torres Strait Islander cultures and to Elders past and present.